Center for Depression Research and Clinical, Peter O'Donnell Jr. Brain Institute and the Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, 75390-9119, USA.
Center for Depression Research and Clinical, Peter O'Donnell Jr. Brain Institute and the Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas, 75390-9119, USA.
Psychiatr Clin North Am. 2023 Jun;46(2):227-245. doi: 10.1016/j.psc.2023.02.002. Epub 2023 Mar 25.
Measurement-based care (MBC) is the systematic screening and ongoing assessment of symptoms, side effects, and adherence to adjust treatments as needed based on these factors. Studies show MBC leads to improved outcomes for depression and treatment-resistant depression (TRD). In fact, MBC may reduce the chances of developing TRD, as it leads to optimized treatment strategies based on symptom changes and compliance. There are many rating scales available for monitoring depressive symptoms, side effects, and adherence. These rating scales can be used in a variety of clinical settings to help guide treatment decisions, including depression treatment decisions.
基于测量的护理（MBC）是系统地筛查和持续评估症状、副作用和依从性，根据这些因素调整治疗。研究表明，MBC 可改善抑郁症和治疗抵抗性抑郁症（TRD）的结果。事实上，MBC 可能会降低发展为 TRD 的机会，因为它会根据症状变化和依从性优化治疗策略。有许多用于监测抑郁症状、副作用和依从性的评分量表。这些评分量表可在多种临床环境中使用，以帮助指导治疗决策，包括抑郁症的治疗决策。
